Metformin lowers HbA1c by an average of 1.1 percentage points when used alone, based on a meta-analysis of 35 randomized trials lasting 12 weeks or longer. That’s a meaningful reduction, enough to move many people from poorly controlled diabetes into a safer range. But blood sugar control is only part of the picture. Metformin also shows benefits for weight, heart health, and overall survival that help explain why it remains the most widely prescribed diabetes medication in the world.
How It Works in Your Body
Metformin’s primary job is reducing the amount of sugar your liver releases into your bloodstream. Your liver constantly produces glucose, even when you don’t need it, and metformin dials that process down. It does this by activating an energy-sensing enzyme in your cells that acts like a metabolic thermostat. When this enzyme switches on, it shifts your liver from producing and storing fat to burning it, while simultaneously reducing glucose output.
Metformin also helps your muscles absorb glucose from your blood more efficiently. Unlike some diabetes medications, it doesn’t force your pancreas to pump out extra insulin, which means it rarely causes dangerously low blood sugar on its own. This dual action, less sugar coming out of the liver and more being absorbed by muscles, is what makes it effective without many of the risks associated with older diabetes drugs.
Blood Sugar Reduction by Dose
Metformin’s effectiveness scales with the dose, but not in a straight line. At 500 mg daily, you can expect an HbA1c drop of roughly 1 percentage point. At 1,000 mg, you get more than half the benefit of the maximum effective dose. At 2,000 mg daily, the reduction reaches about 2 percentage points. Beyond 2,000 mg, there’s little additional glucose lowering, but side effects increase. This ceiling effect is why most doctors aim for 1,500 to 2,000 mg as the target dose.
These numbers represent averages. If your starting HbA1c is higher, you’ll likely see a larger absolute drop. Someone starting at 9% will typically see more dramatic improvement than someone starting at 7.5%, even on the same dose.
How It Compares to Newer Medications
Newer injectable medications have surpassed metformin in raw blood sugar reduction. When added on top of metformin, the strongest of these (tirzepatide at its highest dose) lowered HbA1c by an additional 2.23 percentage points, and injectable semaglutide reduced it by another 1.57 points. These are powerful drugs, but they’re also expensive, often requiring insurance pre-authorization, and they come with their own side effects.
Metformin’s advantage is its combination of effectiveness, safety, low cost, and decades of real-world evidence. It costs pennies per day in generic form and has a side effect profile that doctors understand thoroughly. That’s why guidelines still recommend it as the starting medication for most people with type 2 diabetes, with newer drugs added later if needed.
Weight Loss Effects
Metformin produces modest but real weight loss. In the landmark Diabetes Prevention Program trial, participants on metformin lost an average of 2.1 kg (about 4.6 pounds) over roughly three years, compared to just 0.1 kg in the placebo group. About 30% of people on metformin lost more than 5% of their body weight in the first year.
A more recent real-world study of 154 people with obesity (but no diabetes) found a more encouraging result: an average loss of 5.8 kg (about 12.8 pounds) on metformin, while the control group actually gained weight. Results vary considerably from person to person. Metformin is not a weight loss drug in the way that newer GLP-1 medications are, but for many people it nudges the scale in the right direction rather than contributing to weight gain like insulin or some other diabetes medications do.
For context, lifestyle changes alone (diet and exercise) outperformed metformin in the same prevention trial, producing an average loss of 5.6 kg. Metformin works best for weight when combined with those same lifestyle changes rather than used as a substitute.
Heart and Survival Benefits
Some of metformin’s most compelling data has nothing to do with blood sugar. In a large study of people with type 2 diabetes, metformin users had roughly half the risk of coronary artery disease compared to non-users, and about 38% lower risk of both stroke and heart failure. These aren’t small effects. The longer people stayed on metformin, the greater the cardiovascular protection appeared to be.
The survival data is similarly striking. A post hoc analysis of over 12,000 patients with type 2 diabetes and high cardiovascular risk found that metformin use was associated with a 25% lower risk of death from any cause. A separate systematic review of 17 observational studies found that metformin was linked to lower all-cause mortality even in patients who also had kidney disease, heart failure, or liver disease. These are populations where doctors were historically cautious about prescribing it.
It’s worth noting that much of this cardiovascular and mortality evidence comes from observational studies rather than randomized trials, which means the exact size of the benefit is harder to pin down. Still, the consistency across many studies and populations is what gives researchers confidence that the effect is real.
Side Effects and Tolerability
Gastrointestinal problems are metformin’s most common downside. About 30% of people experience nausea, diarrhea, bloating, or stomach cramps, particularly when starting the medication. The good news is that only about 4% of people find these side effects severe enough to stop taking it. For most, the symptoms ease within a few weeks as the body adjusts.
Starting at a low dose and increasing gradually is the standard approach to minimize stomach trouble. Taking metformin with food also helps. An extended-release version dissolves more slowly in the gut and causes fewer gastrointestinal symptoms for people who can’t tolerate the standard form. Beyond the stomach issues, metformin can reduce absorption of vitamin B12 over time, so long-term users should have their levels checked periodically.
Effectiveness for Prediabetes
Metformin isn’t only used after a diabetes diagnosis. The Diabetes Prevention Program trial showed it reduces the progression from prediabetes to type 2 diabetes, though lifestyle intervention (structured diet and exercise programs aiming for 7% weight loss and 150 minutes of weekly activity) was more effective. Where metformin shines in this context is practicality. Maintaining intensive lifestyle changes over years is difficult for many people, and metformin offers a simpler, sustained layer of protection. Over long-term follow-up in the same trial, participants on metformin maintained an average weight loss of 2.5 kg, suggesting the benefits hold up over time rather than fading.
Despite this evidence, prescribing rates for prediabetes remain low. If your blood sugar is in the prediabetes range and lifestyle changes haven’t been enough, metformin is a well-studied option with a long track record.